The objective of the present invention is to provide: an NOX inhibitor and an NFκB inhibitor, each having excellent activity; and a prophylactic or therapeutic agent for diseases associated with NOX or NFκB, which utilizes the NOX inhibitor or the NFκB inhibitor. In order to achieve this objective, a specific methoxyflavone is used.